Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: June 29, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 23, 2025
TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 21, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
Journal: JCO precision oncology
Published: November 20, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2025
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2025
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: October 30, 2025
Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 26, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas.
Journal: JCO precision oncology
Published: September 24, 2025
Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours.
Journal: Histopathology
Published: September 15, 2025
Last Updated: 09/26/2026